Federal Register / Vol. 86, No. 158 / Thursday, August 19, 2021 / Notices 46715 

notification of preliminary 

determinations by Commerce that 

imports of metal lockers from China 

were subsidized within the meaning of 

section 703(b) of the Act (19 U.S.C. 

1671b(b)) and sold at LTFV within the 

meaning of 733(b) of the Act (19 U.S.C. 

1673b(b)). Notice of the scheduling of 

the final phase of the Commission’s 

investigations and of a public hearing to 

be held in connection therewith was 

given by posting copies of the notice in 

the Office of the Secretary, U.S. 

International Trade Commission, 

Washington, DC, and by publishing the 

notice in the Federal Register on March 

15, 2021 (86 FR 14338). In light of the 

restrictions on access to the Commission 

building due to the COVID–19 

pandemic, the Commission conducted 

its hearing through written testimony 

and video conference on June 24, 2021. 

All persons who requested the 

opportunity were permitted to 

participate. 

The Commission made these 

determinations pursuant to §§ 705(b) 

and 735(b) of the Act (19 U.S.C. 

1671d(b) and 19 U.S.C. 1673d(b)). It 

completed and filed its determinations 

in these investigations on August 13, 

2021. The views of the Commission are 

contained in USITC Publication 5218 

(August 2021), entitled Metal Lockers 

from China: Investigation Nos. 701–TA– 

656 and 731–TA–1533 (Final). 

By order of the Commission. 

Issued: August 16, 2021. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2021–17815 Filed 8–18–21; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 337–TA–1191] 

Certain Audio Players and Controllers, 

Components Thereof, and Products 

Containing Same; Notice of Request 

for Submissions on the Public Interest 

AGENCY: U.S. International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that, 

on August 13, 2021, the presiding chief 

administrative law judge (‘‘CALJ’’) 

issued an Initial Determination on 

Violation of Section 337. The CALJ also 

issued a Recommended Determination 

on Remedy and Bond should a violation 

be found in the above-captioned 

investigation. The Commission is 

soliciting submissions on public interest 

issues raised by the recommended relief 

should the Commission find a violation. 

This notice is soliciting comments from 

the public only. 

FOR FURTHER INFORMATION CONTACT: 

Richard P. Hadorn, Esq., Office of the 

General Counsel, U.S. International 

Trade Commission, 500 E Street SW, 

Washington, DC 20436, telephone (202) 

205–3179. Copies of non-confidential 

documents filed in connection with this 

investigation may be viewed on the 

Commission’s electronic docket (EDIS) 

at https://edis.usitc.gov. For help 

accessing EDIS, please email 

EDIS3Help@usitc.gov. General 

information concerning the Commission 

may also be obtained by accessing its 

internet server at https://www.usitc.gov. 

Hearing-impaired persons are advised 

that information on this matter can be 

obtained by contacting the 

Commission’s TDD terminal, telephone 

(202) 205–1810. 

SUPPLEMENTARY INFORMATION: Section 

337 of the Tariff Act of 1930 provides 

that, if the Commission finds a 

violation, it shall exclude the articles 

concerned from the United States: 

unless, after considering the effect of such 

exclusion upon the public health and 

welfare, competitive conditions in the United 

States economy, the production of like or 

directly competitive articles in the United 

States, and United States consumers, it finds 

that such articles should not be excluded 

from entry. 

19 U.S.C. 1337(d)(1). A similar 

provision applies to cease and desist 

orders. 19 U.S.C. 1337(f)(1). 

The Commission is soliciting 

submissions on public interest issues 

raised by the recommended relief 

should the Commission find a violation, 

specifically: A limited exclusion order 

directed to certain audio players and 

controllers, components thereof, and 

products containing the same that are 

imported, sold for importation, and/or 

sold after importation by respondent 

Google LLC of Mountain View, 

California, that infringe one or more of 

claims 17, 21, 24, and 26 of U.S. Patent 

No. 9,195,258; claims 7, 14, and 22–24 

of U.S. Patent No. 10,209,953; claim 10 

of U.S. Patent No. 9,219,959; claims 1, 

2, and 5 of U.S. Patent No. 8,588,949; 

and/or claims 1, 5, 6, and 12 of U.S. 

Patent No. 10,439,896; and a cease and 

desist order directed to the same. Parties 

are to file public interest submissions 

pursuant to 19 CFR 210.50(a)(4). 

The Commission is interested in 

further development of the record on 

the public interest in this investigation. 

Accordingly, members of the public are 

invited to file submissions of no more 

than five (5) pages, inclusive of 

attachments, concerning the public 

interest in light of the CALJ’s 

Recommended Determination on 

Remedy and Bond issued in this 

investigation on August 13, 2021. 

Comments should address whether 

issuance of the recommended remedial 

orders in this investigation, should the 

Commission find a violation, would 

affect the public health and welfare in 

the United States, competitive 

conditions in the United States 

economy, the production of like or 

directly competitive articles in the 

United States, or United States 

consumers. 

In particular, the Commission is 

interested in comments that: 

(i) Explain how the articles 

potentially subject to the recommended 

remedial orders are used in the United 

States; 

(ii) identify any public health, safety, 

or welfare concerns in the United States 

relating to the recommended orders; 

(iii) identify like or directly 

competitive articles that complainant, 

its licensees, or third parties make in the 

United States which could replace the 

subject articles if they were to be 

excluded; 

(iv) indicate whether complainant, 

complainant’s licensees, and/or thirdparty suppliers have the capacity to 

replace the volume of articles 

potentially subject to the recommended 

orders within a commercially 

reasonable time; and 

(v) explain how the recommended 

orders would impact consumers in the 

United States. 

Written submissions from the public 

must be filed no later than by close of 

business on September 13, 2021. 

Persons filing written submissions 

must file the original document 

electronically on or before the deadlines 

stated above. The Commission’s paper 

filing requirements in 19 CFR 210.4(f) 

are currently waived. 85 FR 15798 (Mar. 

19, 2020). Submissions should refer to 

the investigation number (‘‘Inv. No. 

337–TA–1191’’) in a prominent place on 

the cover page and/or the first page. (See 

Handbook for Electronic Filing 

Procedures, https://www.usitc.gov/ 

documents/handbook_on_filing_

procedures.pdf.). Persons with 

questions regarding filing should 

contact the Secretary (202–205–2000). 

Any person desiring to submit a 

document to the Commission in 

confidence must request confidential 

treatment. All such requests should be 

directed to the Secretary to the 

Commission and must include a full 

statement of the reasons why the 

Commission should grant such 

treatment. See 19 CFR 201.6. Documents 

for which confidential treatment by the 


lotter on DSK11XQN23PROD with NOTICES1
46716 Federal Register / Vol. 86, No. 158 / Thursday, August 19, 2021 / Notices 

Commission is properly sought will be 

treated accordingly. All information, 

including confidential business 

information and documents for which 

confidential treatment is properly 

sought, submitted to the Commission for 

purposes of this Investigation may be 

disclosed to and used: (i) By the 

Commission, its employees and Offices, 

and contract personnel (a) for 

developing or maintaining the records 

of this or a related proceeding, or (b) in 

internal investigations, audits, reviews, 

and evaluations relating to the 

programs, personnel, and operations of 

the Commission including under 5 

U.S.C. Appendix 3; or (ii) by U.S. 

government employees and contract 

personnel, solely for cybersecurity 

purposes. All contract personnel will 

sign appropriate nondisclosure 

agreements. All nonconfidential written 

submissions will be available for public 

inspection on EDIS. 

This action is taken under the 

authority of section 337 of the Tariff Act 

of 1930, as amended (19 U.S.C. 1337), 

and Part 210 of the Commission’s Rules 

of Practice and Procedure (19 CFR part 

210). 

By order of the Commission. 

Issued: August 16, 2021. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2021–17816 Filed 8–18–21; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–887] 

Importer of Controlled Substances 

Application: Galephar Pharmaceutical 

Research Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Galephar has applied to be 

registered as an importer of basic 

class(es) of controlled substance(s). 

Refer to SUPPLEMENTARY INFORMATION

listed below for further drug 

information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before September 20, 2021. Such 

persons may also file a written request 

for a hearing on the application on or 

before September 20, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing must 

be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All requests for a 

hearing should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/OALJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DPW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on July 23, 2021, Galephar 

Pharmaceutical Research Inc., 100 Carr 

198 Industrial Park, Juncos, Puerto Rico 

00777–3873, applied to be registered as 

an importer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Hydromorphone .............. 9150 II 

The company plans to import the 

listed controlled substance in finished 

dosage form for analytical purpose only. 

No other activity for this drug code is 

authorized for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Brian S. Besser, 

Acting Assistant Administrator. 

[FR Doc. 2021–17765 Filed 8–18–21; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–886] 

Importer of Controlled Substances 

Application: Chattem Chemicals, Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Chattem Chemicals, Inc., has 

applied to be registered as an importer 

of basic class(es) of controlled 

substance(s). Refer to SUPPLEMENTARY

INFORMATION listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before September 20, 2021. Such 

persons may also file a written request 

for a hearing on the application on or 

before September 20, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing must 

be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All requests for a 

hearing should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/OALJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DPW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on July 23, 2021, Chattem 

Chemicals, Inc., 3801 Saint Elmo 

Avenue, Chattanooga, Tennessee 

37409–1237, applied to be registered as 

an importer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Methamphetamine ........... 1105 II 

4-Anilino-N-Phenethyl-4- 

Piperidine (ANPP).

8333 II 

Phenylacetone ................. 8501 II 

Coca Leaves ................... 9040 II 

Opium, Raw ..................... 9600 II 

Poppy Straw Concentrate 9670 II 

Tapentadol ...................... 9780 II 

The company plans to import the listed 

controlled substances to manufacture 

bulk controlled substances for sale to its 

customers. The company plans to 

import an intermediate of Tapentadol 

(9780), to bulk manufacture Tapentadol 

for distribution to its customers. No 

other activity for this drug code is 

authorized for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonVerDate Sep<11>2014 17:28 Aug 18, 2021 Jkt 253001 PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 E:\FR\FM\19AUN1.SGM 19AUN1

lotter on DSK11XQN23PROD with NOTICES1

I I